氨酸激酶抑制剂对表观遗传调节者的表达模式的影响
Klaudia Tóth1, Zsuzsanna Gaál1
1Institute of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Cancers
|April 26, 2025
概括
氨酸激酶抑制剂 (TKI) 改变癌症中的表观遗传调节剂. 这项研究揭示了表观遗传编写器,擦拭器和微RNA的显著变化,这表明了改善癌症治疗的新组合疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子遗传学 分子遗传学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 精确瘤学利用分子诊断和向疗法,如氨酸激酶抑制剂 (TKI).
- 有限的数据存在于TKI对表观遗传调节者的影响.
- 表观遗传调节在恶性疾病中起着至关重要的作用.
研究的目的:
- 调查TKI治疗对表观遗传调节器表达的影响.
- 为了分析这些效应在血液恶性瘤和固体瘤.
- 总结有关癌症表观遗传修饰物的现有文献.
主要方法:
- 使用了体外和体内TKI治疗模型.
- 从基因表达总 (GEO) 存储库分析了基因表达数据.
- 进行基因表达模式的统计分析.
主要成果:
- 在TKI治疗后,鉴定了表观遗传记者,擦拭器和微RNA的显著变化.
- 观察到染色体重塑复合体成员的变化.
- 证实了TKI对关键表观遗传分子表达的影响.
结论:
- TKI治疗显著影响癌症中的表观遗传调节器表达.
- 这些发现支持结合TKI与表观遗传药物 (表观药物) 的新疗法策略.
- 这种组合方法可能会导致更少的毒性和更有效的癌症疗法.
相关概念视频
Receptor Tyrosine Kinases
11.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.7K
Epigenetic Regulation
2.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
2.9K
Histone Modification
12.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
12.8K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K


